13F

Stock

Tarsus Pharmaceuticals, Inc.

TARS · held by 1 managers

Reported value

$206.8K

Holders

1

+0 new · −0 exited

Holders’ est. mark

−$3.49K

Price effect on 1 books still in the name

Largest holder

$206.8K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC11.6K$206.8K−$3.49KCut−$63.5K

Positions as of Q3 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.